Stay updated on HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown instead of v3.3.1. There are no changes to the study details, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2025-12-01T11:50:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Minor editorial updates note that PubMed publications are automatically filled and that the revision number has changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:47:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The banner announcing government funding status/NIH operating status was removed; this informational element did not affect core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:23:23.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Substantive study details such as design, outcomes, eligibility criteria, and locations appear unchanged. The changes seem limited to layout and formatting only; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:05:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    - Updated operating status notice due to funding lapse and guidance to official status pages. - Version bumped from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T09:25:16.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to v3.1.0 with removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a previous version reference (v3.0.2) indicating a leaner focus under the new version.
    Difference
    0.2%
    Check dated 2025-09-28T03:07:43.000Z thumbnail image

Stay in the know with updates to HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Clinical Trial page.